7.990USD-7.31%Mkt Cap: 539.27M USDP/E: 19.41Last update: 2026-06-01
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which compr…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap539.27M USD
Enterprise Value874.47M USD
Revenue (TTM)576.30M USD
Gross Profit388.16M USD
Net Income (TTM)22.73M USD
Revenue/Share8.609 USD
Last Price7.990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees940
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)19.41
P/E (Forward)9.39
PEG1.15
EV/EBITDA10.81
EV/Revenue1.52
P/S1.00
P/B3.05
EPS (TTM)0.41
EPS (Forward)0.91
52W Range
5.81040% of range11.25
52W High11.25 USD
52W Low5.810 USD
Profitability
Gross Margin68.33%
Oper. Margin6.73%
EBITDA Margin14.04%
Profit Margin4.00%
ROE12.35%
ROA3.33%
Growth
Revenue Growth6.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF74.67M USD
CapEx (TTM)2.56M USD
FCF Margin10.99%
FCF Yield11.74%
Net Debt252.57M USD
Net Debt/EBITDA3.12
Balance Sheet
Debt/Equity1.60
Current Ratio1.69
Quick Ratio1.06
Book Value/Sh2.793 USD
Cash/Share0.5290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)14.80 USD
Target Range14.00 USD – 16.00 USD
# Analysts5
Ownership
Shares Out.67.75M
Float33.64M
Insiders11.26%
Institutions78.26%
Short Interest
Short Ratio3.1d
Short % Float3.40%
Short % Out.2.33%
Shares Short1.58M
Short (prev mo.)1.35M
Technical
SMA 509.720 (-17.8%)
SMA 2008.087 (-1.2%)
Beta0.72
S&P 52W Chg27.94%
Avg Vol (30d)518.26K
Avg Vol (10d)699.80K
Technical Indicators
RSI (14)32.3
MACD-0.2455
MACD Signal0.0036
MACD Hist.-0.2492
BB Upper11.58 USD
BB Middle10.07 USD
BB Lower8.557 USD
BB Width29.98%
ATR (14)0.5513 USD
Vol Ratio (20d)0.74x